Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Pharmacology

17.02.2021

A clinical trial to verify the effectiveness of a new drug against COVID-19

29.01.2021

Ivermectin could reduce viral transmission of COVID-19

23.11.2020

A database collects genomes of bacteria and their hosts for the development of antibiotics

Organoid images will be key to studying the effect of infection. Image by Sandra Acosta, IBE.
17.11.2020

Human organoids to study COVID-19 infection and treatments more realistically

GPCRs are the target of almost 40% of current drugs. Jana Selent's team has led the creation of a platform that facilitates their study.
20.07.2020

Facilitating drug design: a platform to study GPCRs

A new study by IMIM researchers will help design safer drugs. Image by Joshua Coleman at Unsplash.
05.11.2019

Inside out: looking within our bodies improves drug design

Manuel Pastor, principal investigator at the pharmacoinformatics group at GRIB.
21.03.2019

Manuel Pastor: “We have created one of the world’s largest toxicology database”

The use of animals, mostly rodents, is nowadays still esential for the development of new drugs to improve human health. Image by Rita Casas/PRBB. CC BY-NC-SA.
13.09.2013

Animals in biomedical research

Ferran Sanz is the director of the Research Programme on Biomedical Informatics (GRIB).
18.10.2011

Ferran Sanz: “Habitual competitors are now working together to get better toxicity predictions”

Manuel Pastor, group leader of the PharmacoInformatics group at the GRIB.
15.03.2011

Manuel Pastor: “I owe my scientific vocation to Spiderman”

Margarita Puig research group (IMIM)
10.09.2009

“It is dificult to introduce new effective analgesics”

Drug development is a long and costly process. The clinical assays are the last part. Photo by freestocks.org on Unsplash
14.04.2008

Clinical trials: the long path to the development of new drugs

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2021 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

You are subscribing to receive the newsletter in English. If you would like to receive it in Catalan or Spanish, please change the language settings in our web.

PRBB will use the information you provide on this form to be in touch with you and to provide updates. By clicking below to subscribe, you accept our privacy policy. You can unsubscribe at any time.